Corrigendum to “Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission” [Journal of Controlled Release 294 (2019)216–225](S0168365918307302)(10.1016/j.jconrel.2018.12.027)

Subhra Mandal, Guobin Kang, Pavan Kumar Prathipati, You Zhou, Wenjin Fan, Qingsheng Li, Christopher J. Destache

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Corrigendum to “Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission” [Journal of Controlled Release 294 (2019)216–225](S0168365918307302)(10.1016/j.jconrel.2018.12.027)'. Together they form a unique fingerprint.

Medicine & Life Sciences